Characterization of clinical and immunological parameters during ebola virus infection of rhesus macaques

Viral Immunology

Volumn 28, Issue 1, 2015, Pages 32-41

  Martins, Karen ^a   Cooper, Christopher ^a   Warren, Travis ^a   Wells, Jay ^a   Bell, Todd ^a   Raymond, Jolynne ^a   Stuthman, Kelly ^a   Benko, Jacqueline ^a   Garza, Nicole ^a   Van Tongeren, Sean ^a   Donnelly, Ginger ^a   Retterer, Cary ^a   Dong, Lian ^a   Bavari, Sina ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; VIRUS RNA;

ACCREDITATION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BEHAVIOR; BLOOD CHEMISTRY; BODY TEMPERATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; FLOW CYTOMETRY; HEMATOLOGY; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; LYMPHOCYTE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTHROMBIN TIME; RHESUS MONKEY; ANIMAL; DISEASE MODEL; EBOLAVIRUS; FEMALE; GROWTH, DEVELOPMENT AND AGING; MALE; PATHOLOGY; PRIMATE DISEASE; VIROLOGY;

ANIMALIA; EBOLA VIRUS; MACACA MULATTA; MARBURGVIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; MACACA MULATTA; MALE; PRIMATE DISEASES;

EID: 84920866291     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2014.0085     Document Type: Article

References (27)

1. Baize S, Leroy EM, Georges AJ, et al. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 2002;128:163-168.
2. Baize S, Leroy EM, Georges-Courbot MC, et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999;5:423-426.
3. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea-preliminary report. N Engl J Med 2014;371:1418-1425.
4. Becquart P, Mahlakoiv T, Nkoghe D, et al. Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus. PLoS One 2014;9:e96360.
5. Bradfute SB, Warfield KL, and Bavari S. Functional CD8 + T cell responses in lethal Ebola virus infection. J Immunol 2008;180:4058-4066.
6. Bradfute SB, Braun DR, Shamblin JD, et al. Lymphocyte death in a mouse model of Ebola virus infection. J Infect Dis 2007;196:S296-304.
7. Davis KJ, Anderson AO, Geisbert TW, et al. Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Arch Pathol Lab Med 1997;121:805-819.
8. Ebihara H, Rockx B, Marzi A, et al. Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus. J Infect Dis 2011;204:S991-999.
9. Geisbert TW, Hensley LE, Gibb TR, et al. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000;80:171-186.
10. Geisbert TW, Pushko P, Anderson K, et al. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis 2002;8:503-507.
11. Geisbert TW, Hensley L E, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: Evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003;163:2347-2370.
12. Gupta M, Spiropoulou C, and Rollin PE. Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro. Virology 2007;364:45-54.
13. Jaax NK, Davis KJ, Geisbert TJ, et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996;120:140-155.
14. Ksiazek TG, Rollin PE, Williams AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179:S177-187.
15. Kuhn JH, Bao Y, Bavari S, et al. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol 2013;158:301-311.
16. Leroy EM, Baize S, Debre P, et al. Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol 2001;124:453-460.
17. Leroy EM, Baize S, Volchkov VE, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000;355:2210-2215.
18. Maruyama T, Rodriguez LL, Jahrling PB, et al. Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol 1999;73:6024-6030.
19. Paessler S, and Walker DH. Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol 2013;8:411-440.
20. Panchal RG, Mourich DV, Bradfute S, et al. Induced il-10 splice altering approach to antiviral drug discovery. Nucleic Acid Ther 2014;24:179-185.
21. Reed DS, Hensley LE, Geisbert JB, et al. Depletion of peripheral blood T lymphocytes and NK cells during the course of Ebola hemorrhagic fever in cynomolgus macaques. Viral Immunol 2004;17:390-400.
22. Reed DS, Lackemeyer MG, Garza NL, et al. Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microbes Infect 2011;13:930-936.
23. Shurtleff AC, Warren TK, and Bavari S. Nonhuman primates as models for the discovery and development of ebolavirus therapeutics. Expert Opin Drug Discov 2011;6: 233-250.
24. Twenhafel NA, Mattix ME, Johnson JC, et al. Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques. Vet Pathol 2013;50:514-529.
25. Villinger F, Rollin PE, Brar SS, et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 1999;179: S188-191.
26. Warren TK, Wells J, Panchal RG, et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 2014;508:402-405.
27. Wauquier N, Becquart P, Padilla C, et al. Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 2010;4(10).